Stay updated on Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0. This indicates a new build of the page content and does not change the trial details themselves.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, representing a version bump in the page's revision history.SummaryDifference0.1%

- Check41 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a newer build of the page. The study details and content remain unchanged.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a minor update to the page metadata. This change does not modify the study information or outcomes.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3. This indicates a backend update to the page template and does not change study information or how the page functions for users.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page adds new helper labels and sections (Last verified, Last known status was, How to Read a Study Record, Common Questions, How to Join a Study) and updates the intervention label from 'Intervention / Treatment' to 'Intervention/Treatment' with a revision bump to v3.6.0.SummaryDifference1%

Stay in the know with updates to Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.